Express Scripts 2009 Annual Report Download - page 104

Download and view the complete annual report

Please find page 104 of the 2009 Express Scripts annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 108

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108

Express Scripts 2009 Annual Report 102
No. 10.7 to the Company’s Quarterly Report on Form 10-Q for the quarter ending September 30, 2004.
10.221
Form of Performance Share Award Agreement used with respect to grants of performance shares by
the Company under the Express Scripts, Inc. 2000 Long-Term Incentive Plan, incorporated by
reference to Exhibit No. 10.2 to the Company’s Current Report on Form 8-K filed February 26, 2008.
10.231
Form of Stock Appreciation Right Award Agreement used with respect to grants of stock appreciation
rights under the Express Scripts, Inc. 2000 Long-Term Incentive Plan, incorporated by reference to
Exhibit No. 10.2 to the Company’s Current Report on Form 8-K filed March 7, 2006.
10.241
Form of Restricted Stock Unit Agreement used with respect to grants of restricted stock units by the
Company under the Express Scripts, Inc. 2000 Long-Term Incentive Plan, incorporated by reference to
Exhibit No. 10.4 to the Company’s Current Report on Form 8-K filed March 3, 2009.
10.251
Description of Compensation Payable to Non-Employee Directors, incorporated by reference to
Exhibit No. 10.1 to the Company’s Current Report on Form 8-K filed May 30, 2008.
10.261
Summary of Named Executive Officer 2009 Salaries, 2008 Bonus Awards, 2009 Maximum Bonus
Potential, and 2009 Equity and Performance Awards, incorporated by reference to Exhibit No. 10.1 to
the Company’s Current Report on Form 8-K filed March 3, 2009.
10.27
Form of Indemnification Agreement entered into between the Company and each member of its Board
of Directors, and between the Company and certain key executives (including all of the Company’s
named executive officers), incorporated by reference to Exhibit 10.1 to the Company’s Current Report
on Form 8-K filed December 29, 2006.
10.28
Credit Agreement, dated as of October 14, 2005, among the Company, Credit Suisse, as administrative
agent, Citigroup Global Markets Inc., as syndication agent, Bank of Nova Scotia, Calyon New York
Branch, Deutsche Bank Securities Inc., JPMorgan Chase Bank, N.A., The Royal Bank of Scotland plc,
Sun Trust and Union Bank of California, as co−documentation agents and the lenders named therein,
incorporated by reference to Exhibit No. 10.1 to the Company’s Current Report on Form 8-K filed
October 14, 2005.
10.29
Amendment No. 1 and Consent No. 1 to Credit Agreement, dated as of May 7, 2007, among the
Company, Credit Suisse, as administrative agent, and the lenders named therein, incorporated by
reference to Exhibit No. 10.1 to the Company's Current Report on Form 8-K filed May 11, 2007.
10.30
Pharmacy Benefits Management Services Agreement, dated as of December 1, 2009, between the
Company and WellPoint, Inc., on behalf of itself and certain designated affiliates.
11.1
Statement regarding computation of earnings per share (See Note 1 to the audited consolidated
financial statements).
12.1
Statement regarding computation of ratio of earnings to fixed charges.
18.1
Preferability Letter from Pricewaterhouse Coopers, LLC, the Company’s independent registered public
accounting firm, incorporated by reference to Exhibit No. 18.1 to the Company’s Quarterly Report on
Form 10-Q for the quarter ending September 30, 2008.
21.1
List of Subsidiaries.
23.1
Consent of PricewaterhouseCoopers LLP, an independent registered public accounting firm.
31.1
Certification by George Paz, as Chairman, President and Chief Executive Officer of Express Scripts,
Inc., pursuant to Exchange Act Rule 13a-14(a).
31.2
Certification by Jeffrey Hall, as Executive Vice President and Chief Financial Officer of Express
Scripts, Inc., pursuant to Exchange Act Rule 13a-14(a).
32.1
Certification by George Paz, as Chairman, President and Chief Executive Officer of Express Scripts,